Biosimilars: Still Not Quite Ready for Prime Time

摘要

The United States is the largest bio-logics market in the world and has the highest prices for biologies, which include monoclonal antibodies, therapeutic proteins, immunomodulators, and growth factors. Unlike traditional chemical drugs, most biologies are not distributed via traditional distribution channels but instead are considered "specialty"drugs, which are supplied via specialty pharmacy distribution services. Biologies and so-called specialty Pharmaceuticals represent the highest growth rate phar: maceutical sector in the U.S., outpacing overall performance of the pharmaceutical market.